Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Llibre

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Current HIV/AIDS Reports|February 3, 2022
HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk GroupsD K Nomah, J Reyes-Urueña, J M Llibre, et al.
Journal of Investigational Allergology & Clinical Immunology|April 18, 2018
Eosinophilic Fasciitis in Association With Hypereosinophilic Syndrome in an HIV-Infected Patient With Severe Multiorgan InvolvementN A Richarz, A Olivé Marques, J M Llibre, et al.
Medicina Clinica|February 22, 1992
[Severe leukopenia and thrombocytopenia and transient acquired hypogammaglobulinemia in a patient with infectious mononucleosis]A Aloy Duch, J A Hernández Hernández, E Muñiz Díaz, et al.
HIV Clinical Trials|February 11, 2009
Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiatedA Bonjoch, M J Buzon, J M Llibre, et al.
Revista Clinica Espanola|March 1, 1993
[Endocarditis due to Candida albicans with peripheral arterial embolism and a cerebral mycotic aneurysm in an IV drug addict]J A Hernández Hernández, M González-Moreno Portugal, J M Casan Cava, et al.
The Journal of Infection|July 1, 1995
Efficacy and safety of alpha-interferon treatment for chronic hepatitis C in HIV-infected patients. HIV-Hepatitis Spanish Study GroupV Soriano, J García-Samaniego, R Bravo, et al.
HIV Medicine|April 25, 2019
Primary health care: an opportunity for early identification of people living with undiagnosed HIV infectionR Martin-Iguacel, C Pedersen, J M Llibre, et al.
HIV Medicine|August 5, 2015
Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: the RELAX studyE Pedrol, J M Llibre, M Tasias, et al.
HIV Medicine|May 20, 2008
Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot studyJ M Llibre, A Bonjoch, J Iribarren, et al.
HIV Medicine|February 26, 2015
Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialJ D Baxter, D Dunn, E White, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Current HIV/AIDS Reports|February 3, 2022
HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk GroupsD K Nomah, J Reyes-Urueña, J M Llibre, et al.
Journal of Investigational Allergology & Clinical Immunology|April 18, 2018
Eosinophilic Fasciitis in Association With Hypereosinophilic Syndrome in an HIV-Infected Patient With Severe Multiorgan InvolvementN A Richarz, A Olivé Marques, J M Llibre, et al.
Medicina Clinica|February 22, 1992
[Severe leukopenia and thrombocytopenia and transient acquired hypogammaglobulinemia in a patient with infectious mononucleosis]A Aloy Duch, J A Hernández Hernández, E Muñiz Díaz, et al.
HIV Clinical Trials|February 11, 2009
Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiatedA Bonjoch, M J Buzon, J M Llibre, et al.
Revista Clinica Espanola|March 1, 1993
[Endocarditis due to Candida albicans with peripheral arterial embolism and a cerebral mycotic aneurysm in an IV drug addict]J A Hernández Hernández, M González-Moreno Portugal, J M Casan Cava, et al.
The Journal of Infection|July 1, 1995
Efficacy and safety of alpha-interferon treatment for chronic hepatitis C in HIV-infected patients. HIV-Hepatitis Spanish Study GroupV Soriano, J García-Samaniego, R Bravo, et al.
HIV Medicine|April 25, 2019
Primary health care: an opportunity for early identification of people living with undiagnosed HIV infectionR Martin-Iguacel, C Pedersen, J M Llibre, et al.
HIV Medicine|August 5, 2015
Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: the RELAX studyE Pedrol, J M Llibre, M Tasias, et al.
HIV Medicine|May 20, 2008
Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot studyJ M Llibre, A Bonjoch, J Iribarren, et al.
HIV Medicine|February 26, 2015
Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialJ D Baxter, D Dunn, E White, et al.
Pageof 6